Evofosfamide
艾伏磷酰胺
Report date: 2026/05/28 20:00:21
NME
Base Information
Drug NameEvofosfamide
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[28]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[19]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesThreshold
China Registration ClassN/A
Develop Information
Active CompaniesImmunoGenesis IncUniversity Health Network (Uhn)
Inactive CompaniesUT Health San AntonioThreshold PharmaceuticalsEmd Serono Inc +[6]
Active Indications +[4]
Inactive Indications +[24]